An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act as lightbulbs, enabling scientists to better see inside living cells to ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

Dental floss could eventually do much more than improve oral hygiene. A new study led by Texas Tech University and the University of North Carolina suggests that the thin filament could eventually ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...